Tag: Drug Pricing

Novartis pushes for new pricing strategy in Japan | Dominion Funds

Novartis pushes for new pricing strategy in Japan | Dominion Funds

Swiss pharmaceutical giant Novartis is urging Japan to consider a new pricing model for medicines that link payment to patient outcomes. This is not new ground for Novartis: the company has experimented with similar pricing strategies elsewhere, and has been amongst the most innovative players in the sector when it comes to thinking about how […]

Intas Pharma: Intas launches biosimilar Bevacizumab with aggressive pricing | ET HealthWorld

Intas Pharma: Intas launches biosimilar Bevacizumab with aggressive pricing | ET HealthWorld

For Roche Avastin is one of its blockbuster drug raking in sales worth $7 billion annually, the drug maker has been making several attempts to stall biosimilar drug launches of its cancer drugs in a bid to ward off competition. Intas spokesperson said that the company has followed all due process in getting the approval […]

Miami Healthcare Executives Advise National Audience About Impending Price Transparency | PRWeb

Miami Healthcare Executives Advise National Audience About Impending Price Transparency | PRWeb

The SHSMD conference attracted nearly 2,000 healthcare marketing professionals, and the event included sessions from some of the nation’s most distinguished thought leaders in the healthcare marketing and communications space, including Weinbach, Irizarry, and Klass. “Thanks to high-deductible health plans and increasing insurance premiums, the healthcare cost burden is shifting, and consumers bear a greater […]

Prescription drug pricing is totally broken, even for generics—here’s what happened — Quartz

Prescription drug pricing is totally broken, even for generics—here’s what happened — Quartz

Much less attention has been paid to the price of prescription drugs that tens of millions Americans take every day–that is, the 85% of prescriptions that treat common chronic conditions such as high blood pressure, high cholesterol, chronic pain, diabetes, and depression–and are usually generic medications, not brand-name drugs. Generics are the versions of drugs […]

Medical innovation has a price: BioNJ Roundtable — Biopharma execs share what’s behind drug pricing | NJBIZ

Medical innovation has a price: BioNJ Roundtable — Biopharma execs share what’s behind drug pricing | NJBIZ

It’s no secret that biopharmaceutical companies have become the target of heavy criticism from politicians and consumers due to high drug prices, especially at a time when health care reform in the U.S. has become a hot-button topic. The topic is especially of interest in New Jersey, given that some of the state’s largest employers […]

Health minister to consider U.S. drug firms’ views in pricing overhaul | Japan Today

Health minister to consider U.S. drug firms’ views in pricing overhaul | Japan Today

“We will thrash out a drastic revision by the year-end, while hearing opinions of interested parties through Central Social Insurance Medical Council.” The council is an expert panel that advises the ministry and canvasses the views of industry representatives. Japan wants to cut healthcare costs and drug prices even if this provokes opposition from U.S. […]

Allscripts launches Prescription Price Transparency initiative Strengthened by strategic partnerships, company aims to deliver real-time information on prescription affordability | Markets Insider

Allscripts launches Prescription Price Transparency initiative Strengthened by strategic partnerships, company aims to deliver real-time information on prescription affordability | Markets Insider

Allscripts Real-Time Health System (RTHS) is launching a journey toward next-level patient care. The conceptual initiative aims to work with partner companies to enable technology that will deliver real-time information on: The medication price from the health plan or pharmacy benefit manager (PBM) The cash price What alternative therapies and their cost Competitive prices at […]

Lilly Plans Cuts as Pricing Pressure Drives New-Drug Push | Bloomberg Quint

Lilly Plans Cuts as Pricing Pressure Drives New-Drug Push | Bloomberg Quint

(Bloomberg) — Eli Lilly & Co. plans to cut 8.5 percent of its workforce in a bid to free up resources to fund new drugs, amid acute pricing pressure for some of its biggest products. The Indianapolis company said some of the 3,500 job cuts will come from early retirements, with about 2,000 positions set […]

Editorial: California needs prescription drug transparency | The Mercury News

Editorial: California needs prescription drug transparency | The Mercury News

Drug makers argue that the bill is a first step toward price controls that will decimate their research and development work. Pharmaceutical companies certainly deserve a reasonable return on their substantial investments in research and development. But if they reveal a pricing strategy that seems justified, it could have the opposite effect, relieving the pressure […]

Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications | Digital Journal

Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications | Digital Journal

“Truveris’ data-driven platform enables employers to create a more symmetrical buying process for prescription drug coverage by demystifying pricing strategies in PBM contracts and driving more transparent competition,” said Tom Rodgers, SVP & Managing Director at McKesson Ventures. “It also helps Biopharma make smarter decisions about where and how it subsidizes patient assistance programs. The […]